A psychiatric-mental health nurse practitioner recently began prescribing controlled substances that are part of a medication-assisted treatment (MAT) program for opioid abuse. The PMHNP must check the prescription drug monitoring program (PMP) website at least every 90 days for patients who receive these prescriptions. Which of the following best describes the purpose of the PMP?

Choice A reason: While PMP data may reveal patterns suggestive of inappropriate prescribing, its primary function is not to police prescribers but to support safe prescribing practices. Choice B reason: The PMP allows prescribers to review controlled substance prescriptions linked to their patients and DEA numbers. It helps identify potential misuse, diversion, and overlapping prescriptions, supporting clinical decision-making and regulatory compliance. Choice C reason: The PMP monitors prescribing across all licensed providers, not just nurse practitioners and physician assistants. This choice inaccurately limits its scope. Choice D reason: The PMP tracks all controlled substance prescriptions, not just those for patients with substance use disorders. It is a broad surveillance and safety tool.